Antibodies are a stalwart tool in biomedical research. Most commonly used are animal-derived polyclonal and monoclonal antibodies (mAbs), and nonanimal-derived recombinant mAbs. According to Simon ...

Monoclonal antibodies are the building blocks of some of the most important medical treatments in the world. But they have limitations. For example, the large size of the molecules mean monoclonal ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...

Monoclonal antibodies (mAbs) are a class of biologic drugs used to treat rheumatoid arthritis if other treatments aren’t effective. mAbs target specific parts of the immune system to reduce ...

Monoclonal antibodies were once the star of COVID-19 outpatient treatments. Since they first became available in 2020 – even before the first vaccines – more than 3.5 million infusions of the ...

Scientists can circumvent these challenges and keep their research moving forward with Bio X Cell’s in vivo antibodies, which are formulated in preservative-free PBS, tested for pathogens and ...

Important adverse events included infusion-related and hypersensitivity reactions in 25 of 306 immunocompromised participants (8.2%) who received pemivibart and anaphylaxis in 4 of 623 participants (0 ...

In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody that specifically targets a certain type of breast cancer cell. Their ...